Partners in Research
Georgetown researchers have been responsible for numerous groundbreaking discoveries including:
- invention of the CAT scan
- development of the first artificial heart valve
- the country’s first clinical trial using gene therapy to slow the progress of Alzheimer’s disease
- codevelopment of Gardasil (the first vaccine for cervical cancer)
- creation of Allegra (the popular antihistamine drug)
How does Partners in Research work?
Georgetown University Medical Center faculty are eligible for the Partners in Research grants to receive critical seed funding to pursue innovative ideas that help to address some of the world’s biggest medical challenges.
How can I become a Partner in Research?
You can become a Partner by making a gift of any size to the program each grant year (July 1–June 30).
What does it mean to be a Partner?
Each year, a diverse group of researchers present during Partners in Research programs. Partners have opportunities to engage with researchers directly by hearing about their projects, asking one-on-one questions, and learning about the ground-breaking scientific research being pursued at GUMC. Partners will have opportunities to join lab tours, an annual innovation showcase, and various other Partner’s-only activities.
Why is philanthropy so important to biomedical research?
With limited federal funding, the environment for biomedical researchers is extremely competitive. Promising discoveries that could improve or save lives go unexplored unless philanthropists like our Partners take the lead.
By pooling gifts made to the Partners in Research program, our Partners can collectively support multiple research projects at one time. As a result, every gift has an expanded impact.
Learn more about supporting biomedical research at Georgetown by exploring our ways to contribute funding and downloading our brochure about Partners in Research.
If you have questions or would like to get involved, please contact a member of our staff.
Meg Pagonis
Senior Director of Development, Georgetown University Medical Center
202-687-7152
meg.pagonis@georgetown.edu
Program Impact
Georgetown University Medical Center is home to a robust, disease-focused research enterprise that spans multiple disciplines and promotes lifesaving research. The Partners in Research program has been created to allow donors to join forces with the researchers who conduct this high-level research.
The link between traumatic brain injury (TBI) and Alzheimer’s disease
“The Partners in Research program provided the stepping stone I needed to gather critical preliminary data to apply for federal research funding. Since the conclusion of my Partners in Research funding in 2014, my group has published 19 research papers, and I have been awarded $5.3 million from the National Institutes of Health for my innovative research plans to improve memory and prevent cognitive decline after traumatic brain injury. We are working on how to recover lost information from the traumatized brain to give hope to the many patients who live with forgotten memories.”
The link between traumatic brain injury (TBI) and Alzheimer’s disease
“The Partners in Research program provided the stepping stone I needed to gather critical preliminary data to apply for federal research funding. Since the conclusion of my Partners in Research funding in 2014, my group has published 19 research papers, and I have been awarded $5.3 million from the National Institutes of Health for my innovative research plans to improve memory and prevent cognitive decline after traumatic brain injury. We are working on how to recover lost information from the traumatized brain to give hope to the many patients who live with forgotten memories.”
Infographic: Success by the Numbers
Since 2010
If you have questions or would like to get involved, please contact a member of our staff.
Meg Pagonis
Senior Director of Development, Georgetown University Medical Center
202-687-7152
meg.pagonis@georgetown.edu
Projects Funded by Partners in Research
In 2011, Georgetown University Medical Center Dean for Research Robert Clarke, PhD, DSc, invited top GUMC researchers to submit research proposals for the inaugural funding year of the Partners in Research program. The submissions were reviewed by a committee of experts from various research backgrounds who followed the stringent proposal review guidelines used by the National Institutes of Health. Five finalists were selected to present their proposals for consideration at the first Partners selection meeting. The three projects ranked highest by the Partners were awarded $30,000-50,000 grants.
Since then, Partners in Research members have contributed more than $1 million and funded 31 projects.
Grant Recipients: Fiscal Year 2019
- Defining the appropriate therapies for patients with triple negative breast cancer and a high risk of recurrence (Filipa Lynce, MD, Louis Weiner, MD, Claudine Isaacs, MD)
- Establishing the capital lung cancer screening registry at LCCC (Dejana Braithwaites, PhD, FRS, Eric Anderson, MD, Pranay Krishnan MD)
- Using transcranial direct current stimulation to treat HIV-associated neurocognitive disorders (Xiong Jiang, PhD, Peter Turkeltaub, MD, PhD, Princy Kumar, MD)
- How does aging affect our ability to remember words? (Michael Ullman, PhD, Jana Reifegerste, PhD)
- Breakthrough Award: Age-related macular degeneration (Nady Golestaneh, PhD, MSc)
-
Fiscal Year 2018
- β2 Containing Subtypes of Nicotinic Acetylcholine Receptors in Body Weight Regulation (Ghazaul Dezfuli, PhD, Kenneth Kellar, PhD)
- Paternal Pre-Conception Stress, Epigenetics and Neuroblastoma Development (Joanna Kitlinska, PhD, Sonia De Assis, PhD)
- Improving the Efficacy of Treatments for Alexia with tDCS (Rhonda Friedman, PhD)
- Translational Approach to reduce HIV-Associated Neurocognitive Disorders (Italo Moccheti, PhD, Valeriya Avdoshina, MD, PhD)
- Attenuating Cognitive Decline with Angiotensin Receptor Antagonists (Patrick Forcelli, PhD, Kathryn Sandberg, PhD, Robert Speth, PhD)
- Cortical Stimulation Through Scalp Electrodes to Induce Sleep as a Safe Treatment for Insomnia (Gholam Motamedi, MD, Jian-Young Wu, PhD, Peter Turkeltaub, MD, PhD)
-
Fiscal Year 2017
- Improving Antidepressant Treatments by Understanding the Role of MMPs (Katherine Conant, Kenneth Kellar)
- Exploring Brain Function to Shed Light on Autism and its Potential Treatments (Lawrence Kromer, John Partridge)
- Investigation of Mechanisms of Vasodilation in Pregnancy for the Prevention and Treatment Preeclampsia (Crystal West)
- Assessing the Benefit of Combination Therapy for Treatment of Pancreatic Cancer (Shahin Assefnia, PhD)
- The Effects of Opioid Taper on Pain Responses in Chronic Pain Patients (Peggy Compton, RN, PhD, Dennis Murphy, MD and Derek L. Thompson, MD)
- Validation of Plk2 as a novel therapeutic target for Alzheimer’s disease (Daniel Pak, PhD)
- Interleukin-4 Induced Protein 1 as a Biomarker and Treatment Option in Multiple Sclerosis (Jeffrey Huang, PhD)
- Single-Blinded, Randomized Assessment of Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine Versus Exparel and Bupivacaine of Placebo (Eleni Tousimis)
-
Fiscal Year 2016
- Biomarkers of Stroke Recovery (Matthew Edwardson)
- Adult Human Islets can be Expanded Indefinitely for Curing Diabetes (G. Ian Gallicano)
- Investigating a Novel Enzyme in Multiple Sclerosis (Jeffrey Huang)
- Validation of a New Drug Target Candidate for Alzheimer’s Disease (Daniel Pak)
-
Fiscal Year 2015
- Developing new Targets for Combating Alzheimer’s Disease (Daniel Pak)
- Identifying Children with Diabetes at High Risk for Strokes and Heart Attacks (Evgenia Gourgari)
- A Promising Molecule for Treatment and Diagnosis of Pancreatic Cancer (Shahin Assefnia)
-
Fiscal Year 2014
- Improving Prevention and Treatment Strategies for Osteoporosis (Gerard Ahern)
- Protecting our Brains from Ongoing Trauma After Injury (Mark Burns, Juan Saavedra)
-
Fiscal Year 2013
- Discovering a Drug That Kills Cancer Cells in the Laboratory (Rebecca Riggins)
- Discovering a Better Way to Determine what Drug Dose is Right for You (John VanMeter, Christopher Albanese, Valeriy Korostyshevskiy)
-
Fiscal Year 2012
- Can Healthy Young Adults Reveal Brain Differences that Predict Alzheimer’s Disease Before It Develops? (Tim Mhyre, Adam Green, Bill Rebeck)
- Creation of Retinal Cells from Human Skin Cells to Treat Age-related Macular Degeneration (Nady Golestaneh)
- Novel, Single Pill for Both Hypertension and Chronic Kidney Disease (Milton Brown, Christopher Wilcox)